Brian Kaminsky, MD
Interventional Cardiology · Mechanicsville, VANPI 1053398198
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Abbott accounts for 60.7% of it on its own, with 34 other manufacturers making up the rest. Reporting peaked in 2021 at $7,500 and has fallen 72.2% since, to $2,082 in 2025.
Across 328 payments — averaging $102.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$20K
- Boston Scientific$4K
- Corindus Inc.$2K
- Asahi Intecc USA, Inc.$2K
- Medtronic$867
- Teleflex LLC$504
- plus $4K from 29 others
What the payments were for
- Consulting fees$10,00030%
- Travel & lodging$5,44716%
- Food & beverage$18,02154%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 120 | $20,332 |
| Boston Scientific | 48 | $3,984 |
| Corindus Inc. | 10 | $2,495 |
| Asahi Intecc USA, Inc. | 14 | $1,708 |
| Medtronic(2 entities) | 10 | $867 |
| Teleflex LLC | 6 | $504 |
| Shockwave Medical, Inc | 5 | $485 |
| Abiomed | 6 | $472 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 21 | $346 |
| Siemens Medical Solutions USA, Inc. | 4 | $250 |
| AstraZeneca | 9 | $246 |
| Novartis | 12 | $224 |
| Edwards Lifesciences | 3 | $211 |
| Pfizer | 8 | $139 |
| Atricure, Inc. | 3 | $136 |
| Kestra Medical Technology Services, Inc. | 5 | $135 |
| Johnson & Johnson | 7 | $107 |
| Cardiva Medical, Inc. | 4 | $99 |
| E.r. Squibb & Sons, L.L.C. | 7 | $97 |
| Cardiovascular Systems Inc. | 2 | $93 |
| Terumo Medical Corporation | 2 | $72 |
| Amgen | 4 | $71 |
| Impulse Dynamics (USA) Inc. | 1 | $68 |
| Merck | 3 | $45 |
| Novo Nordisk | 2 | $45 |
| Philips North America LLC | 2 | $33 |
| Alnylam Pharmaceuticals Inc. | 2 | $32 |
| Scpharmaceuticals Inc. | 1 | $26 |
| Angiodynamics, Inc. | 1 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $22 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $22 |
| Lexicon Pharmaceuticals, Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $21 |
| Boehringer Ingelheim | 1 | $20 |
| Medicomp Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Xience V coronary stent system$7,867
- Dragonfly OCT$5,000
- CorPath GRX$2,380
- ASAHI PTCA Guide Wire$1,081
- GENERAL - THERAPIES$1,026
- Xience Sierra Coronary Stent System$747
- GENERAL - STENTS$424
- XIENCE SIERRA$409
- MitraClip$377
- MitraClip System$356
- OPTIS$286
- SYNERGY$286
- TRICLIP$260
- Optis Coronary Imaging System$256
- GUIDELINER$241
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$241
- Asahi Peripheral Vascular Wires$241
- COROFLOW$220
- PERIPHERAL VASCULAR$182
- GENERAL VASCULAR ACCESS$150
How this compares
$33,468 in reported general payments places this provider in the 85th percentile of 176 interventional cardiology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 210 | $198,892 |
| EntrestoSacubitril/Valsartan | 139 | $144,859 |
| Repatha SureclickEvolocumab | 49 | $47,801 |
| XareltoRivaroxaban | 31 | $33,933 |
| FarxigaDapagliflozin Propanediol | 19 | $17,453 |
| Metoprolol Succinate | 309 | $2,994 |
| Ezetimibe | 60 | $1,690 |
| Midodrine Hcl | 13 | $1,685 |
| Rosuvastatin Calcium | 133 | $1,271 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 96 | $1,173 |
| Amlodipine Besylate | 219 | $1,029 |
| Carvedilol | 117 | $970 |
| Losartan Potassium | 122 | $939 |
| Atorvastatin Calcium | 85 | $914 |
| Nebivolol Hcl | 11 | $874 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $139 | $198,892210 claims |
| NovartisEntresto | $224 | $144,859139 claims |
| Johnson & JohnsonXarelto | $107 | $33,93331 claims |
| AstraZenecaFarxiga | $246 | $17,45319 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 176 interventional cardiology providers in Virginia.
Other interventional cardiology in Mechanicsville
- Mohammad ChaudhryMechanicsville$29K
- Deepak TalrejaVirginia Beach$1.5M
- Rajiv TayalFredericksburg$984K
- Gansevoort DunningtonRichmond$440K
- Matthew SummersNorfolk$308K
- Noah JonesFalls Church$238K
- Michael GenVirginia Beach$207K
- Jeremy BockLeesburg$202K
- Wayne BatchelorFalls Church$196K
- Matthew SherwoodFalls Church$193K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.